ACI, The Nation’s Premier Provider of Life Sciences Intellectual Property Conferences, is bringing its renowned Hatch-Waxman Series to Boston.
ACI’s Hatch-Waxman Boot Camp has been designed to give counsel and advisors to brand name and generic drug companies—and biopharmas—critical insights into commercialization and the pre-approval process, and also provide you an in-depth review of Hatch-Waxman and other IP basics relative to small molecules and biologics. This conference will lay the necessary foundation for you to comprehend thoroughly the dynamics of the applicable patent life cycles for pharmaceutical and biopharmaceutical products and business development plans.
Hollie L. Baker will be speaking on the safe harbor under Section 271(e)(1).